Thread regarding Teva Pharmaceutical Industries Ltd. layoffs

Profile

Teva Pharmaceutical Industries Ltd

PO Box 3190

5 Basel Street

Petach Tikva 49131, Israel

Phone: +972 (3) 926 7267

Fax: +972 (3) 923 4050

Email: info@teva.co.il

Website: http://www.tevapharm.com

Contact:

Board of Directors

Dr Phillip Frost, Chairman, Board of Directors Dr Phillip Frost

Prof Moshe Many, Vice Chairman, Board of Directors Prof Moshe Many

Roger Abravanel, Director, Board of Directors Roger Abravanel

Abraham Cohen, Director, Board of Directors Abraham Cohen

Amir Elstein, Director, Board of Directors Amir Elstein

Chaim Hurvitz, Director, Board of Directors Chaim Hurvitz

Prof Elon Kohlberg, Director, Board of Directors Prof Elon Kohlberg

Prof Roger Kornberg, Director, Board of Directors Prof Roger Kornberg

Prof Richard Alan Lerner, Director, Board of Directors Prof Richard Alan Lerner

Joseph Nitzani, Director, Board of Directors Joseph Nitzani

Prof Yitzhak Peterburg, Director, Board of Directors Prof Yitzhak Peterburg

Dan Propper, Director, Board of Directors Dan Propper

Prof Dafna Schwartz, Director, Board of Directors Prof Dafna Schwartz

Ory Slonim, Director, Board of Directors Ory Slonim

Dan Suesskind, Director, Board of Directors Dan Suesskind

Erez Vigodman, Director, Board of Directors Erez Vigodman

Management

Isaac Abravanel, Group Executive Vice President Human Resources and Chief Integration Officer, Management Isaac Abravanel

Dr Carlo De Notaristefani, President and Chief Executive Officer, Global Operations, Management Dr Carlo De Notaristefani

Eyal Desheh, Group Executive Vice President, Chief Financial Officer, Management Eyal Desheh

Richard Egosi, Group Executive Vice President, Chief Legal Officer and Company Secretary, Management Richard Egosi

Ron Grupel, Chief Internal Auditor, Management Ron Grupel

Dr Michael Hayden, President of Global R 7110 (Israel)

Founded: 1944.

Principal Activities: Development, production and marketing of generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients.

Mergers and Acquisitions: In 2008, the Company completed the acquisition of CoGenesys Inc, USA, Bentley Pharmaceuticals Inc, USA, and Barr Pharmaceuticals Inc., USA. In August 2010, the Company acquired the Merckle ratiopharm Group. In January 2011, the Company acquired Laboratoire Théramex and Corporación Infarmasa. In July 2011, the Company acquired Taiyo Pharaceutical Industry Co Ltd, Japan. In October 2011, the Company acquired Cephalon Inc, USA.

Trade Names: Azilect (R), Copaxone (R), Amrix (R), Fentora (R), Provigil (R), Nuvigil (R), Treanda (R).

Subsidiary Companies: Cephalon Inc (100%) (USA); CT Arzneimittel GmbH (100%) (Germany); Ivax Argentina S.A. (100%) (Argentina); Laboratoire Théramex SAM (100%) (Monaco); Laboratorio Chile S.A. (99.60%) (Chile); Lemery Desarrollo y Control SA (100%) (Mexico); Pharmachemie Holding BV (100%) (Netherlands); PLIVA HRVATSKA d.o.o. (100%) (Croatia); ratiopharm GmbH Taisho Pharmaceutical Industries Ltd (100%) (Japan); Taiyo Pharmaceutical Industry Co Ltd (100%) (Japan); Teva API BV (100%) (Netherlands); Teva API Inc (100%) (USA); Teva Canada Ltd (100%) (Canada); Teva Czech Industries s.r.o. (100%) (Czech Republic); TEVA Gyógyszergyár Zrt (100%) (Hungary); Teva Italia Srl (100%) (Italy); Teva Ltd (100%) (Russia); TEVA Magyarország Gyógyszerforgalmazó Zrt (100%) (Hungary); Teva Pharma SL (100%) (Spain); Teva Pharmaceuticals Europe BV (100%) (Netherlands); Teva Pharmaceuticals Polska Sp zoo (100%) (Poland); Teva Pharmaceuticals USA Inc (100%) (USA); Teva Santé SAS (100%) (France); Teva UK Ltd (100%) (UK).

Latest Sales turnover figure converted to USD: $18,312,000,000.

by
| 1813 views | | no replies yet
Post ID: @OP+N0fyvFG

There are no replies in this thread yet. Be the first to post a reply below:

Post a reply

: